111 related articles for article (PubMed ID: 4014000)
1. Influence of long-acting nitrate therapy on the risk of reinfarction, sudden death, and total mortality in survivors of acute myocardial infarction.
Rapaport E
Am Heart J; 1985 Jul; 110(1 Pt 2):276-80. PubMed ID: 4014000
[TBL] [Abstract][Full Text] [Related]
2. Identification of sudden death risk factors in acute and chronic coronary artery disease.
Vismara LA; Vera Z; Foerster JM; Amsterdam EA; Mason DT
Am J Cardiol; 1977 May; 39(6):821-8. PubMed ID: 871108
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the clinical and hemodynamic effects of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate in acute myocardial infarction].
Lazebnik LB; Tereshchenko SN; Gendel'man AM
Kardiologiia; 1991 Oct; 31(10):13-5. PubMed ID: 1753569
[TBL] [Abstract][Full Text] [Related]
4. When is drug therapy warranted to prevent sudden cardiac death?
Singh BN
Drugs; 1991; 41 Suppl 2():24-46. PubMed ID: 1711967
[TBL] [Abstract][Full Text] [Related]
5. Sudden death and its relation to QT-interval prolongation after acute myocardial infarction: two-year follow-up.
Wheelan K; Mukharji J; Rude RE; Poole WK; Gustafson N; Thomas LJ; Strauss HW; Jaffe AS; Muller JE; Roberts R
Am J Cardiol; 1986 Apr; 57(10):745-50. PubMed ID: 2870632
[TBL] [Abstract][Full Text] [Related]
6. Can the mode of death be predicted in patients with angiographically documented coronary artery disease?
Puddu PE; Bourassa MG; Lespérance J; Hélias J; Danchin N; Goulet C
Clin Cardiol; 1983 Aug; 6(8):384-95. PubMed ID: 6616985
[TBL] [Abstract][Full Text] [Related]
7. [Sudden death among 1,000 patients with myocardial infarction: incidence and contributory factors. KYSMI Study Group].
Kambara H; Kinoshita M; Nakagawa M; Sakurai T; Kawai C
J Cardiol; 1995 Feb; 25(2):55-61. PubMed ID: 7897607
[TBL] [Abstract][Full Text] [Related]
8. Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database Initiative.
Coiro S; Girerd N; Rossignol P; Bauersachs J; Pitt B; Fay R; Ambrosio G; Solomon SD; Dickstein K; Zannad F
Clin Res Cardiol; 2017 Sep; 106(9):722-733. PubMed ID: 28455597
[TBL] [Abstract][Full Text] [Related]
9. Atrial fibrillation during acute myocardial infarction: association with all-cause mortality and sudden death after 7-year of follow-up.
Berton G; Cordiano R; Cucchini F; Cavuto F; Pellegrinet M; Palatini P
Int J Clin Pract; 2009 May; 63(5):712-21. PubMed ID: 19392921
[TBL] [Abstract][Full Text] [Related]
10. Prognostic importance of digitalis after acute myocardial infarction.
Madsen EB; Gilpin E; Henning H; Ahnve S; LeWinter M; Mazur J; Shabetai R; Collins D; Ross J
J Am Coll Cardiol; 1984 Mar; 3(3):681-9. PubMed ID: 6693640
[TBL] [Abstract][Full Text] [Related]
11. Importance of peak enzyme level and reinfarction while attempting to intervene myocardial infarction process.
Mukherjee D
J Indian Med Assoc; 1989 Oct; 87(10):229-31. PubMed ID: 2630597
[TBL] [Abstract][Full Text] [Related]
12. Intravenous isosorbide dinitrate in patients with refractory pump failure and acute myocardial infarction.
Rabinowitz B; Tamari I; Elazar E; Neufeld HN
Circulation; 1982 Apr; 65(4):771-8. PubMed ID: 7060256
[TBL] [Abstract][Full Text] [Related]
13. Instantaneous cardiac death in the posthospital period after acute myocardial infarction.
Sweeney MO; Moss AJ; Eberly S
Am J Cardiol; 1992 Dec; 70(18):1375-9. PubMed ID: 1359781
[TBL] [Abstract][Full Text] [Related]
14. Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction.
Singh BN
Am J Cardiol; 1990 Sep; 66(9):9C-20C. PubMed ID: 1699400
[TBL] [Abstract][Full Text] [Related]
15. Oral ISDN for the treatment of patients with acute myocardial infarction.
Grosser KD; Schuster P; Freund M; Knoch K; Sturm A
Z Kardiol; 1983; 72 Suppl 3():147-51. PubMed ID: 6666216
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of antiarrhythmic drugs in prevention of sudden coronary death.
Winkle RA
Ann N Y Acad Sci; 1982; 382():247-57. PubMed ID: 6979282
[No Abstract] [Full Text] [Related]
17. Effect of isosorbide dinitrate on enzymatically estimated infarction size and on clinical condition of the patients of acute myocardial infarction.
Mukherjee D; Lodh SK; Sengupta M; Maity AK; Mondal AK; Ghose JC
Indian J Pathol Microbiol; 1990 Apr; 33(2):144-50. PubMed ID: 2391145
[TBL] [Abstract][Full Text] [Related]
18. Relation of ventricular arrhythmias in the late hospital phase of acute myocardial infarction to sudden death after hospital discharge.
Vismara LA; Amsterdam EA; Mason DT
Am J Med; 1975 Jul; 59(1):6-12. PubMed ID: 1138552
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Death in the first 6 months after myocardial infarction: potential for mortality reduction in the early posthospital period.
Moss AJ; DeCamilla J; Davis H
Am J Cardiol; 1977 May; 39(6):816-20. PubMed ID: 860693
[TBL] [Abstract][Full Text] [Related]
20. [Long-term therapy following myocardial infarct with isosorbide dinitrate in a low and high dose].
Kober G; Bettinger R; Klepzig H; Burger W; Schräder R; Kadel C; Fuchs H; Morawe G; Kaltenbach M
Z Kardiol; 1989; 78 Suppl 2():122-6; discussion 142-4. PubMed ID: 2511684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
